Srinivas Akkaraju - Feb 12, 2024 Form 4 Insider Report for Mineralys Therapeutics, Inc. (MLYS)

Role
Director, 10%+ Owner
Signature
/s/ Srinivas Akkaraju
Stock symbol
MLYS
Transactions as of
Feb 12, 2024
Transactions value $
$7,499,993
Form type
4
Date filed
2/14/2024, 09:07 PM
Previous filing
Dec 26, 2023
Next filing
Feb 29, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MLYS Common Stock Award $7.5M +556K +12.29% $13.50 5.07M Feb 12, 2024 See footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities held directly by Samsara BioCapital, L.P. ("Samsara LP"). Dr. Akkaraju has voting and investment power over the shares held by Samsara LP and, accordingly, may be deemed to beneficially own the shares held by Samsara LP. Dr. Akkaraju disclaims beneficial ownership in these shares except to the extent of his pecuniary interest therein.